Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05808634 · ClinicalTrials.gov registry record · Phase 1
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
A Phase 1 study of Advanced Adenocarcinoma, sponsored by BioAtla.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 168
- Enrollment target
- 9
- Study locations
NCT05808634: Recruiting Phase 1 study of Advanced Adenocarcinoma, sponsored by BioAtla.
NCT05808634 is a Phase 1 study of Advanced Adenocarcinoma that is actively recruiting participants, run by BioAtla. The registered enrollment target is 168 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (180% higher). The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05808634, a Phase 1 study of Advanced Adenocarcinoma, is actively recruiting participants, sponsored by BioAtla.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 168 participants
- Enrollment target
- 9
- Study locations
Study Summary
The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
Primary Outcome
Phase 1 Part 1: Safety Profile of BA3182
Conditions Studied
Interventions
- DRUG BA3182
Study Locations (9)
California
- UC Irvine - Irvine
- USC Norris Comprehensive Cancer Center - Los Angeles
Illinois
- Northwestern University - Chicago
- University of Illinois - Chicago
Ohio
- The Christ Hospital Cancer Center - Cincinnati
- University Hospitals Cleveland Medical Center - Cleveland
Connecticut
- Yale Cancer Center - New Haven
Michigan
- Karmanos Cancer Institute - Detroit
Washington
- Fred Hutch Cancer Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2023-07-14 |
| Est. Completion | 2028-09-15 |
| Phase | Phase 1 |
What NCT05808634 shows while recruiting
NCT05808634 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (180% higher).
The record links to 1 condition, with Advanced Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which BA3182 is the first listed.
NCT05808634 lists 9 locations in 6 states (California, Illinois, Ohio).
Frequently Asked Questions
What is clinical trial NCT05808634 about?
NCT05808634 is a clinical study titled "Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.". The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma
What is the current status of trial NCT05808634?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 168 participants. The study started on 2023-07-14. Estimated completion is 2028-09-15.
What conditions does trial NCT05808634 study?
This clinical trial studies the following conditions: Advanced Adenocarcinoma.
What interventions are being tested in trial NCT05808634?
The interventions under investigation include: BA3182 (DRUG).
Who is sponsoring clinical trial NCT05808634?
This trial is sponsored by BioAtla, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05808634 being conducted?
This trial has 9 study locations across California, Connecticut, Illinois, Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05808634's enrollment target sits among peer trials
168 327th of 2000 higher than 1,671 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI